Victoria S. P.
- Country
- Spain
- Department
- Oncology
Research Overview
- Phase I Dose-Escalation and Expansion Study of BI 3819026 Monotherapy and in Combination with Ezabenlimab in Patients with Unresectable Advanced or Metastatic Solid Tumors
- Phase 1/2 Open‑Label Study of Oral GSK5460025A Monotherapy and Combination Therapy Assessing Safety and Efficacy in dMMR/MSI‑H Tumors, colorectal and endometrial cancer
- Phase 1/1b Study of BMS‑986463 in Patients With Advanced Malignant Tumors Including High‑Grade Serous Ovarian Carcinoma, Uterine Serous Carcinoma, and NSCLC
Data & Insights
Has run more than one trial at 14 of 45 partner sites.
Specializations
Oncology Research
The investigator specializes in treating advanced solid malignancies, with particular emphasis on cases where standard therapeutic approaches have shown limited effectiveness.
- Treatment-resistant tumors
- Novel therapeutic approaches
- Advanced cancer management
Their research focus includes evaluating innovative therapeutic strategies for patients who have experienced disease progression following conventional treatments.
Clinical Development
The investigator's expertise centers on the clinical evaluation of experimental cancer therapeutics, with a particular focus on determining optimal dosing strategies and safety profiles.
- Drug safety assessment
- Dose optimization
- Treatment tolerability
Their work involves comprehensive evaluation of therapeutic agents' safety parameters and establishing appropriate dosing protocols.
Treatment Response Assessment
The investigator specializes in evaluating anti-tumor activity and therapeutic responses in advanced cancers using standardized assessment criteria.
- Response monitoring
- Treatment efficacy evaluation
- Clinical outcomes assessment
Their expertise includes systematic monitoring of treatment outcomes in advanced malignancies using established evaluation protocols.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.